275 related articles for article (PubMed ID: 23897285)
21. Chronic pain management in pregnancy and lactation.
Coluzzi F; Valensise H; Sacco M; Allegri M
Minerva Anestesiol; 2014 Feb; 80(2):211-24. PubMed ID: 23857445
[TBL] [Abstract][Full Text] [Related]
22. Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.
Mahadevan U; McConnell RA; Chambers CD
Gastroenterology; 2017 Feb; 152(2):451-462.e2. PubMed ID: 27769809
[TBL] [Abstract][Full Text] [Related]
23. Perception of Reproductive Health in Women with Inflammatory Bowel Disease.
Ellul P; Zammita SC; Katsanos KH; Cesarini M; Allocca M; Danese S; Karatzas P; Moreno SC; Kopylov U; Fiorino G; Torres J; Lopez-Sanroman A; Caruana M; Zammit L; Mantzaris G
J Crohns Colitis; 2016 Aug; 10(8):886-91. PubMed ID: 26783343
[TBL] [Abstract][Full Text] [Related]
24. Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding.
Gisbert JP
Inflamm Bowel Dis; 2010 May; 16(5):881-95. PubMed ID: 19885906
[TBL] [Abstract][Full Text] [Related]
25. Management of inflammatory bowel diseases during pregnancy.
Dignass AU; Hartmann F; Sturm A; Stein J
Dig Dis; 2009; 27(3):341-6. PubMed ID: 19786762
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease.
Saha S; Wald A
Expert Opin Drug Saf; 2012 Nov; 11(6):947-57. PubMed ID: 22954378
[TBL] [Abstract][Full Text] [Related]
27. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients.
Moskovitz DN; Bodian C; Chapman ML; Marion JF; Rubin PH; Scherl E; Present DH
Am J Gastroenterol; 2004 Apr; 99(4):656-61. PubMed ID: 15089898
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy and nursing.
Burakoff R; Opper F
Gastroenterol Clin North Am; 1995 Sep; 24(3):689-98. PubMed ID: 8809243
[TBL] [Abstract][Full Text] [Related]
29. Management of inflammatory bowel disease in pregnancy.
Ng SW; Mahadevan U
Expert Rev Clin Immunol; 2013 Feb; 9(2):161-73; quiz 174. PubMed ID: 23390947
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory bowel disease in the pregnant woman.
Hanan IM
Compr Ther; 1993; 19(3):91-5. PubMed ID: 8222593
[TBL] [Abstract][Full Text] [Related]
31. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
Daperno M; Sostegni R; Canaparo R; Serpe L; Lavagna A; Crocellà L; Castagno F; Vernetto A; Rigazio C; Ercole E; D'Antico S; Pera A; Zara G; Rocca R
Aliment Pharmacol Ther; 2009 Oct; 30(8):843-53. PubMed ID: 19650826
[TBL] [Abstract][Full Text] [Related]
32. Drug therapy of inflammatory bowel disease in fertile women.
Kroser J; Srinivasan R
Am J Gastroenterol; 2006 Dec; 101(12 Suppl):S633-9. PubMed ID: 17177868
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease.
de Meij TG; Jharap B; Kneepkens CM; van Bodegraven AA; de Boer NK;
Aliment Pharmacol Ther; 2013 Jul; 38(1):38-43. PubMed ID: 23675854
[TBL] [Abstract][Full Text] [Related]
34. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
Metge CJ; Blanchard JF; Peterson S; Bernstein CN
Am J Gastroenterol; 2001 Dec; 96(12):3348-55. PubMed ID: 11774948
[TBL] [Abstract][Full Text] [Related]
35. [Inflammatory diseases of the digestive system and pregnancy: clinical case and review of the literature].
Restellini A
Schweiz Rundsch Med Prax; 1989 May; 78(19):560-4. PubMed ID: 2662327
[TBL] [Abstract][Full Text] [Related]
36. Republished curriculum based clinical review: IBD: reproductive health, pregnancy and lactation.
Hendy P; Chadwick G; Hart A
Postgrad Med J; 2015 Apr; 91(1074):230-5. PubMed ID: 25862708
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
Coelho J; Beaugerie L; Colombel JF; Hébuterne X; Lerebours E; Lémann M; Baumer P; Cosnes J; Bourreille A; Gendre JP; Seksik P; Blain A; Metman EH; Nisard A; Cadiot G; Veyrac M; Coffin B; Dray X; Carrat F; Marteau P;
Gut; 2011 Feb; 60(2):198-203. PubMed ID: 21115547
[TBL] [Abstract][Full Text] [Related]
38. [Inflammatory bowel diseases and pregnancy].
Shitrit AB; Goldin E; Grisaru-Granovsky S
Harefuah; 2014 Dec; 153(12):742-6, 751. PubMed ID: 25654917
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation.
Puchner A; Gröchenig HP; Sautner J; Helmy-Bader Y; Juch H; Reinisch S; Högenauer C; Koch R; Hermann J; Studnicka-Benke A; Weger W; Puchner R; Dejaco C
Wien Klin Wochenschr; 2019 Jan; 131(1-2):29-44. PubMed ID: 30643992
[TBL] [Abstract][Full Text] [Related]
40. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
